©The Author(s) 2024.
World J Gastrointest Surg. Jun 27, 2024; 16(6): 1537-1547
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1537
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1537
Table 3 Multivariate analysis for overall survival
| Prognostic factors | P value | HR (95%CI) | |
| Maximal tumor diameter | 0.667 | 1 (0.99-1.01) | |
| T (ref T1) | |||
| T2 | 0.055 | 2.04 (0.99-4.20) | |
| T3 | 0.002 | 3.09 (1.51-6.31) | |
| T4 | 0.005 | 7.44 (1.82-30.35) | |
| N (ref N0) | |||
| N1 | 0.077 | 1.35 (0.97-1.89) | |
| N2 | 0.075 | 1.46 (0.96-2.21) | |
| M3 | 0.002 | 1.99 (1.28-3.11) | |
| G (ref G1) | |||
| G2 | 0.103 | 1.42 (0.93-2.16) | |
| G3 | 0.387 | 1.25 (0.76-2.05) | |
| Venous thrombus (ref negative) | Positive | < 0.001 | 1.8 (1.34-2.42) |
| Perineurial invasion (ref negative) | Positive | 0.088 | 1.29 (0.96-1.71) |
| Adjuvant chemotherapy (ref no) | Yes | 0.738 | 0.95 (0.71-1.27) |
| NRLN (ref ≤ 21) | > 21 | 0.004 | 0.66 (0.50-0.87) |
- Citation: Tang JM, Huang SJ, Chen QB, Wu HS, Qiao GB. Optimal extent of lymphadenectomy improves prognosis and guides adjuvant chemotherapy in esophageal cancer: A propensity score-matched analysis. World J Gastrointest Surg 2024; 16(6): 1537-1547
- URL: https://www.wjgnet.com/1948-9366/full/v16/i6/1537.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i6.1537